Stockmarket regulator NZ RegCo says it is “assessing” Ryman Healthcare’s compliance with continuous disclosure obligations after the company revealed a potential breach of debt covenants was behind its $902 million capital raise announced last week.
The money raised is to pay back US
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).